Position in DXCM
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,890,527
+$349,451 QoQ
Shares Held
42,918
+6.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#343
of 973 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026OP Asset Management Ltd holds $61,883,894 across 12 Medical Devices names. DXCM ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
193,646 | $17,571,438 | |
| 2 | SYK |
Stryker Corp
|
39,935 | $12,573,135 | |
| 3 | BSX |
Boston Scientific Corp
|
164,724 | $7,030,420 | |
| 4 | EW |
Edwards Lifesciences Corp
|
63,844 | $5,775,328 | |
| 5 | PODD |
Insulet Corp
|
32,922 | $5,012,374 | |
| 6 | ATEC |
Alphatec Holdings, Inc.
|
480,111 | $4,152,960 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
50,624 | $3,240,442 | |
| 8 | DXCM |
Dexcom Inc
This page
|
42,918 | $2,890,527 |
All Filings in DXCM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,890,527 | 42,918 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,541,076 | 40,463 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $3,142,221 | 47,344 | Shares | Sole | 2026-04-21 | |
| 2025-09-30 | $3,185,777 | 47,344 | Shares | Sole | 2026-04-20 | |
| 2025-06-30 | $4,006,698 | 45,901 | Shares | Sole | 2026-04-20 | |
| 2025-03-31 | $3,235,921 | 47,385 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||